Tag

Tag: Novartis

08/08/2017 2 mins

Update: The FDA Unanimously Recommends Approval of the First CAR-T Therapy

11/07/2017 3 mins

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

07/07/2017 1 min

More News! Biotechs Push G20 for Support in Battle against Antibiotic Resistance

26/06/2017 1 min

New Results from Novartis in the Race to Launch the First CAR-T

22/06/2017 1 min

Novartis Scores Major Phase III Win with New Cardiovascular Drug

20/06/2017 2 mins

Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials

19/06/2017 2 mins

Update: Novartis Takes on Blood Cancer with new Biosimilar Approval

15/06/2017 1 min

Novartis Announces New Data for its Psoriasis Blockbuster Cosentyx

15/06/2017 2 mins

UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech

02/05/2017 2 mins

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

25/04/2017 2 mins

Novartis Negotiates its Way into the US Migraine Market

19/04/2017 3 mins

UPDATE: Novartis broadens CAR-T onslaught with FDA endorsement

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.